NCT00092469View on ClinicalTrials.gov

Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
DiphtheriaTetanusPertussisHepatitis BPoliomyelitis
Interventions
BIOLOGICAL

V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092469 - Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) | Biotech Hunter | Biotech Hunter